Literature DB >> 28463525

Upper airway and skin symptoms in allergic and non-allergic asthma: Results from the Swedish GA2LEN study.

Mary Kämpe1, Maria Vosough1, Andrei Malinovschi2, Mohammad Alimohammadi3, Kjell Alving4, Bertil Forsberg5, Jan Lötvall6, Roelinde Middelveld7,8, Barbro Dahlén9, Christer Janson1.   

Abstract

BACKGROUND: Allergic and non-allergic asthma are viewed as separate entities, despite sharing similarities. The aims of this study were to determine differences in symptoms from the upper airways and the skin in allergic and non-allergic asthma. The secondary aims were to identify childhood risk factors and to compare quality of life in the two asthma groups.
METHODS: This cohort (age 17-76 years) consisted of 575 subjects with allergic or non-allergic asthma and 219 controls. The participants participated in an interview, spirometry, FeNO, skin prick test, and responded to the Mini Asthma Quality of Life Questionnaire.
RESULTS: Self-reported allergic rhinitis was significantly more common in both allergic and non-allergic asthma (82.3 and 40.7%) groups compared with the controls. The prevalence of chronic rhinosinusitis (CRS) was similar in both asthma groups. Eczema was significantly more common in both asthmatic groups (72.3 and 59.8%) than controls (47.0%) (p < 0.001 and p = 0.012). Severe respiratory infection in childhood and parental allergy were risk factors for both allergic and non-allergic asthma groups. Quality of life was significantly lower in non-allergic than allergic asthma groups (p = 0.01).
CONCLUSION: Concomitant symptoms from the upper airways and the skin were significantly more common in both allergic and non-allergic asthma. This indicates that non-allergic asthma has a systemic component with similarities to what is found in allergic asthma. There were similarities in the childhood risk factor pattern between the two types of asthma but asthma-related quality of life was lower in the non-allergic asthma group.

Entities:  

Keywords:  Allergy; asthma; eczema; rhinitis

Mesh:

Substances:

Year:  2017        PMID: 28463525     DOI: 10.1080/02770903.2017.1326132

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  4 in total

1.  Effects of indoor coal fine particulate matter on the expression levels of inflammatory factors in ovalbumin-induced mice.

Authors:  Jie Yu; Yin Tang; Jie Xu
Journal:  Toxicol Res (Camb)       Date:  2018-11-01       Impact factor: 3.524

Review 2.  The NLRP3 inflammasome as a new target in respiratory disorders treatment.

Authors:  Katarzyna Leszczyńska; Dominika Jakubczyk; Sabina Górska
Journal:  Front Immunol       Date:  2022-09-20       Impact factor: 8.786

3.  Study of atopic multimorbidity in subjects with rhinitis using multiplex allergen component analysis.

Authors:  Viiu Blöndal; Fredrik Sundbom; Magnus P Borres; Marieann Högman; Kjell Alving; Andrei Malinovschi; Christer Janson
Journal:  Clin Transl Allergy       Date:  2020-02-21       Impact factor: 5.871

4.  Multimorbidity in asthma, association with allergy, inflammatory markers and symptom burden, results from the Swedish GA2 LEN study.

Authors:  Viiu Blöndal; Andrei Malinovschi; Fredrik Sundbom; Anna James; Roelinde Middelveld; Karl A Franklin; Bo Lundbäck; Christer Janson
Journal:  Clin Exp Allergy       Date:  2020-10-25       Impact factor: 5.018

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.